Robot brain surgery trial aims to boost recovery after stroke

NCT ID NCT06465719

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether an AI-guided robotic system can improve outcomes for people with a moderate brain bleed (basal ganglia hemorrhage). About 330 adults will be randomly assigned to receive either the AI-assisted minimally invasive surgery or standard care. The goal is to see if the robotic approach leads to better functional recovery and less disability.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BASAL GANGLIA HEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

basal ganglia cerebrovascular disorder Basal Ganglia Hemorrhage intracerebral hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • the Second Affiliated Hospital of Zhejiang University School of Medicine

    RECRUITING

    Hangzhou, Zhejiang, 310009, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••